Fact CheckerSign in

NCT05461989Completed

Physical Activity Barriers in Adolescent Hypertension Patients

Source: ClinicalTrials.gov · Last updated 22 Sept 2025

Brief summary (registry, in English)

One of the most prevalent chronic disorders in children, especially teenagers, is hypertension . The prevalence of hypertension has significantly increased in recent years, particularly with the rise in obesity. It has been demonstrated that hypertension is a significant, controllable risk factor for cardiovascular disease and that it is linked to atherosclerosis in children. Additionally, in patients with hypertension who were monitored from infancy to adulthood, it was discovered that the unfavorable cardiac alterations and vascular damage linked to hypertension were linked to early cardiovascular disease in adults. Therefore, the key to preventing cardiovascular disease in children and adolescents-especially when risk factors like obesity, diabetes, or chronic renal disease are present-is early diagnosis and effective treatment of hypertension. Insufficient exercise and sedentary lifestyles are additional risk factors for pediatric hypertension.Investigating physical activity barrier in teenage hypertension patients is vital in light of all these factors as well as studies on adolescents' inadequate physical activity. The literature is lacking studies examining the obstacles to physical exercise faced by people with adolescent hypertension, hence this topic is open for investigation.

Status (registry)
Completed
Study type
Observational
Enrollment
66 (actual)
First submitted
9 Jul 2022
Start date
30 Sept 2022
Primary completion date
30 Mar 2024
Lead sponsor
Hacettepe University
NCT number
NCT05461989

What you commit to

  • Study type: Observational
  • Participants enrolled: 66
  • From 30 Sept 2022 to the primary completion date, 30 Mar 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving hormone replacement therapy,
  • Receiving hormone replacement therapy,

Other illness

  • Having a neurological, cognitive or orthopedic disease that will affect the measurements,
  • Severe respiratory system disease (FEV1 \<35%; FVC \<50%),
  • Having acute infection,
  • Having malignancy,
  • Having uncontrolled hypertension,
  • Individuals with diabetes will not be included in the study.
    • For Secondary Hypertension
  • Having a neurological, cognitive or orthopedic disease that will affect the measurements,
  • Severe respiratory system disease (FEV1 \<35%; FVC \<50%),
  • Having acute infection,
  • Having malignancy,
  • Having uncontrolled hypertension,
  • Individuals with diabetes will not be included in the study.

Lab values

  • Ejection fraction less than 50%,
  • Ejection fraction less than 50%,

Other

  • Body mass index \>40 kg/m²,
  • Body mass index \>40 kg/m²,

Who the study is looking for

  • Being 10-19 years old,
  • Being diagnosed with primary hypertension,
  • Being clinically stable and no drug/drug dose changes for the last four weeks,
  • Determined to be voluntary to participate in the study
  • Being 10-19 years old,
  • Being diagnosed with secondary hypertension,
  • Being clinically stable and no drug/drug dose changes for the last four weeks,
  • Not being under high-dose glucocorticoid therapy (2 mg/kg/day),
  • Not taking intravenous biologic or conventional immunosuppressive therapy (including pulsed steroids) in the past month
  • Determined to be voluntary to participate in the study

Criteria the registry did not label

  • For Primary Hypertension

Age in the registry: 10 years to 19 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Hacettepe University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.